Dr. Giancarlo MORETTI
2003. Nóos signed an exclusive concession contract for Italy with BioGaia AB for the probiotic Lactobacillus reuteri DSM 17938; the product is launched on the Italian market under the trademark “Reuterin®“. Scientific research and clinical development are always on-going.
2004. Nóos signed a sub-licensing contract with Italchimici SpA for the probiotic Lactobacillus reuteri DSM 17938 in Italy. The product was launched on the Italian market under the trademark “Reuflor®“. In 2016 Italchimici SpA entered the Recordati SpA group.
2012. Nóos submitted an international patent and launched a product line in the respiratory field for the Italian market: this was the result of its own scientific research. The products are registered under the trademark “LinfoVir plus®“.
2014. Nóos signed a distribution contract with Norgine Italia Srl for the distribution of “Movicol Bambini®” in Italy.
2017. Nóos entered Elite project which is an innovative platform created by the Italian Stock Exchange to offer services dedicated to ambitious companies willing to get in touch with a community of excellence; the project allows companies to deal with the best international models and the best practices to seize all the business opportunities.